# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-091766
Filing Date
2023-08-15
Accepted
2023-08-15 09:53:41
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-08-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | tm2322261d2_ars.pdf | ARS | 599977
| Complete submission text file | 0001104659-23-091766.txt |  | 827920

Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-12584 | Film No.: 231173518
SIC: 2834 Pharmaceutical Preparations